Lv6
1620 积分 2023-09-18 加入
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic Non‒Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
1个月前
已完结
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma
2个月前
已完结
Immediate smoking cessation support during lung cancer screening: long-term outcomes from two randomised controlled trials
2个月前
已完结
Cytokine-mediated dysregulation of zonula occludens-1 properties in human brain microvascular endothelium
3个月前
已完结
Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease
4个月前
已完结
Relevance of CD6-Mediated Interactions in T Cell Activation and Proliferation
5个月前
已完结
A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas
5个月前
已完结
Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents
5个月前
已关闭
A Basidiomycete Probably Causing Onychomycosis*
8个月前
已完结
皖公网安备34019202002308
